v3.26.1
SUBSEQUENT EVENTS (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF ALLOCATION OF FAIR VALUE IN PRIVATE PLACEMENT

The allocation was calculated as follows:

 

Component 

Standalone

Fair Value

  

% of Total

Fair Value

  

Allocation of

Proceeds

  

Allocation per

Share/Warrant

 
Common Stock (16,614,001 shares)  $    %  $   $ 
Common Stock (16,614,001 shares)  $1,366,246    59.28%  $425,370   $0.0256 
Warrants (15,383,334 warrants)  938,613    40.72%  292,230   0.0190 
Total  $2,304,861    100%  $717,600      
SCHEDULE OF STOCKHOLDER’S EQUITY

 

Issuances of Common Stock subsequent to December 31, 2025

 

Date     # Shares   Amount   Price/Share   Type  Notice
1/01/2026      108,147,731   $13,607,433   $0.126       
1/23/2026  a*  4,716,000    145,701    0.031   private placement   
1/23/2026  a*  —    95,339    —   warrants   
1/10/2026  c   75,000    5,550    0.074   consulting fees   
2/10/2026  c   239,155    10,888    0.046   consulting fees   
3/10/2026  c   184,000    8,150    0.044   consulting fees   
4/15/2026      113,361,886   $13,873,061   $0.122       

 

Issuances of Warrants subsequent to to December 31, 2025

 

Date     # Warrants   wavg Term   wavg Exerc   Type  Notice
1/01/2026      16,675,364    4.6   $0.13       
1/23/2026  a*  4,366,667    5.0    0.12   private placement   
4/15/2026      21,042,031    4.6   $0.12       

 

* Around January 23, 2026, the Company issued 4,366,667 shares of Common Stock at a price of $0.06 per share, as well as 4,366,667 (100% coverage) 5-year warrants exercisable to Common Stock at $0.12 per share, as part of a $262,000 private placement offering. A commission of $20,960 (8%) was awarded to the (Member FINRA / SIPC) broker, along with 349,333 (8%) shares of Common Stock, was directly integrated into the purchase. Generating $241,040 ($0.051/share) in net cash received.
   
a The Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.
c The Company claims an exemption from the registration requirements of the Securities Act pursuant to the Exchange Exemption in Rule 3(a)(9) of the Securities Act.
d The Company claims an exemption from the registration requirements of the Securities Act for the Compensatory Benefit Plan pursuant to Rule 701 of the Securities Act.
SCHEDULE OF SHARES AWARDED

Shares awarded, but not yet issued, under the 2021 Stock Plan subsequent to December 31, 2025:

 

Date     # Shares   Amount   Price/Share   Type  Notice
1/01/2026      1,232,125   $93,395   $0.076   stipend   
1/30/2026  **   30,000,000    1,278,600    0.043   bonus 

affiliate

3/31/2026      

254,240

    

11,415

    

0.045

  

stipend

   
4/15/2026      31,486,365   $1,383,410   $0.044       

 

**

The Board of Directors awarded the CEO 6,000,000 Preferred Shares, a 1:5 conversion, as a performance grant in recognition of his role in executing the Company’s first commercial distribution agreement and advancing capital funding initiatives.

 

The shares will be issued as Preferred Stock, but are for comparative purpose expressed as Common share equivalents in this table.
Unit Offering [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF ALLOCATION OF FAIR VALUE IN PRIVATE PLACEMENT

The allocation was calculated as follows:

 

Component  Standalone
Fair Value		   % of Total
Fair Value		   Allocation of
Proceeds		   Allocation per
Share/Warrant		 
Common Stock (4,716,000 shares)  $    %  $   $ 
Common Stock (4,716,000 shares)  $283,381    60.45%  $145,701   $0.0309 
Warrants (4,366,667 warrants)   185,430    39.55%   95,339    0.0218 
Total  $468,811    100%  $241,040